Macrophage depletion ameliorates glycerol-induced acute kidney injury in mice

Jin H Kim1, Dong-Won Lee, Myeong H Jung

  • 1Biomedical Research Institute, Gyeongsang National University, Jinju, Republic of Korea.

Abstract

Insights

Depleting renal macrophages using liposome-encapsulated clodronate (LEC) significantly protects against acute kidney injury (AKI) in a mouse model. Macrophage depletion reduces tubular apoptosis and inflammation, preventing kidney dysfunction.

Area of Science:

  • Nephrology
  • Immunology
  • Cell Biology

Background:

  • Acute kidney injury (AKI) pathogenesis involves complex cellular and inflammatory processes.
  • Renal macrophages play a critical, yet not fully understood, role in AKI development.
  • Investigating macrophage function is crucial for developing targeted AKI therapies.

Purpose of the Study:

  • To elucidate the specific role of renal macrophages in glycerol-induced rhabdomyolysis and subsequent AKI.
  • To evaluate the therapeutic potential of macrophage depletion in preventing AKI.
  • To analyze the molecular mechanisms underlying macrophage-mediated kidney injury.

Main Methods:

  • Established a mouse model of AKI using intramuscular glycerol injection.
  • Utilized liposome-encapsulated clodronate (LEC) for targeted renal macrophage depletion.
  • Assessed kidney injury markers, tubular cell apoptosis, and inflammatory mediator expression post-treatment.

Main Results:

  • Glycerol injection induced significant renal dysfunction and tubular damage, evidenced by increased serum creatinine.
  • Macrophage depletion with LEC markedly reduced the number of renal macrophages (CD45(+)CD11b(+)Ly6c(+) and F4/80(+)).
  • LEC pretreatment attenuated glycerol-induced tubular cell apoptosis (decreased caspase-9, p53; increased Bcl-2) and suppressed key inflammatory pathways (NF-κB, MCP-1, ICAM-1, iNOS, COX-2).

Conclusions:

  • Renal macrophages are key contributors to AKI development in this rhabdomyolysis model.
  • Depletion of renal macrophages effectively prevents AKI by inhibiting tubular cell apoptosis.
  • Targeting renal macrophages represents a promising therapeutic strategy for mitigating AKI and renal dysfunction.

Related Concept Videos